Suppr超能文献

慢性淋巴细胞白血病的诊断与治疗:巴西慢性淋巴细胞白血病研究组的建议

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia.

作者信息

Rodrigues Celso Arrais, Gonçalves Matheus Vescovi, Ikoma Maura Rosane Valério, Lorand-Metze Irene, Pereira André Domingues, Farias Danielle Leão Cordeiro de, Chauffaille Maria de Lourdes Lopes Ferrari, Schaffel Rony, Ribeiro Eduardo Flávio Oliveira, Rocha Talita Silveira da, Buccheri Valeria, Vasconcelos Yuri, Figueiredo Vera Lúcia de Piratininga, Chiattone Carlos Sérgio, Yamamoto Mihoko

机构信息

Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Hospital Sírio Libanês, São Paulo, SP, Brazil.

Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Fleury Medicina e Saúde, São Paulo, SP, Brazil.

出版信息

Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):346-357. doi: 10.1016/j.bjhh.2016.07.004. Epub 2016 Aug 20.

Abstract

Chronic lymphocytic leukemia is characterized by clonal proliferation and progressive accumulation of B-cell lymphocytes that typically express CD19, CD5 and CD23. The lymphocytes usually infiltrate the bone marrow, peripheral blood, lymph nodes, and spleen. The diagnosis is established by immunophenotyping circulating B-lymphocytes, and prognosis is defined by two staging systems (Rai and Binet) established by physical examination and blood counts, as well as by several biological and genetic markers. In this update, we present the recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia for the diagnosis and treatment of chronic lymphocytic leukemia. The following recommendations are based on an extensive literature review with the aim of contributing to more uniform patient care in Brazil and possibly in other countries with a similar social-economic profile.

摘要

慢性淋巴细胞白血病的特征是B淋巴细胞的克隆性增殖和渐进性积聚,这些B淋巴细胞通常表达CD19、CD5和CD23。淋巴细胞通常浸润骨髓、外周血、淋巴结和脾脏。通过对循环B淋巴细胞进行免疫表型分析来确诊,预后则由通过体格检查和血细胞计数建立的两个分期系统(Rai和Binet)以及几个生物学和遗传标志物来定义。在本次更新中,我们展示了巴西慢性淋巴细胞白血病研究小组关于慢性淋巴细胞白血病诊断和治疗的建议。以下建议基于广泛的文献综述,旨在促进巴西以及其他社会经济状况相似的国家提供更统一的患者护理。

相似文献

1
Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia.
Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):346-357. doi: 10.1016/j.bjhh.2016.07.004. Epub 2016 Aug 20.
2
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Am J Hematol. 2019 Nov;94(11):1266-1287. doi: 10.1002/ajh.25595. Epub 2019 Oct 4.
4
Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.
Am J Hematol. 2013 Sep;88(9):803-16. doi: 10.1002/ajh.23491.
5
8
[Chronic lymphocytic leukemia--the old and the new].
Ther Umsch. 2004 Feb;61(2):151-6. doi: 10.1024/0040-5930.61.2.151.
9
[Chronic lymphocytic leukemia].
Dtsch Med Wochenschr. 2013 Oct;138(42):2153-66. doi: 10.1055/s-0033-1349491. Epub 2013 Oct 8.

引用本文的文献

1
Animal Venoms as Potential Antitumor Agents Against Leukemia and Lymphoma.
Cancers (Basel). 2025 Jul 14;17(14):2331. doi: 10.3390/cancers17142331.
3
Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders.
Indian J Hematol Blood Transfus. 2023 Oct;39(4):684-690. doi: 10.1007/s12288-022-01622-1. Epub 2023 Jan 3.
4
Expert consensus on the management of chronic lymphocytic leukaemia in Asia.
Clin Exp Med. 2023 Oct;23(6):2895-2907. doi: 10.1007/s10238-023-01007-2. Epub 2023 Feb 16.
8
Anti-globulin test positivity indicates advanced disease in Indian CLL patients.
Am J Blood Res. 2021 Apr 15;11(2):157-162. eCollection 2021.
9
Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):111-117. doi: 10.31557/APJCP.2021.22.1.111.
10
Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods.
Hematol Transfus Cell Ther. 2020 Jul-Sep;42(3):261-268. doi: 10.1016/j.htct.2020.05.005. Epub 2020 Jun 25.

本文引用的文献

1
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
3
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
N Engl J Med. 2016 Jan 28;374(4):311-22. doi: 10.1056/NEJMoa1513257. Epub 2015 Dec 6.
5
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
N Engl J Med. 2015 Dec 17;373(25):2425-37. doi: 10.1056/NEJMoa1509388. Epub 2015 Dec 6.
6
Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL.
Blood. 2016 Jan 21;127(3):279-86. doi: 10.1182/blood-2015-08-634816. Epub 2015 Nov 17.
8
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.
Blood. 2015 Dec 17;126(25):2686-94. doi: 10.1182/blood-2015-03-630947. Epub 2015 Oct 15.
9
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study.
Blood. 2015 Aug 13;126(7):842-50. doi: 10.1182/blood-2014-12-617522. Epub 2015 Jun 26.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验